Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index87
i10-index219
Publications1,493
Citations31,331

Grants

2 total · 1 active

NIH #P50CA265826

Project 1

Active
Amount
$300K–$400K
Period
2022-08-01 → 2027-07-31
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #R21CA234816

Study of Plasma Next Generation Sequencing for Remote Assessment, Characterization, Evaluation of Patients with ALK Drug Resistance (SPACEWALK)

Amount
$100K–$200K
Period
2018-12-15 → 2021-11-30
PIs
1

Awarded at DANA-FARBER CANCER INST

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

2 total · 1 active

NIH #P50CA265826

Project 1

Active
Amount
$300K–$400K
Period
2022-08-01 → 2027-07-31
PIs
1

Awarded at DANA-FARBER CANCER INST

NIH #R21CA234816

Study of Plasma Next Generation Sequencing for Remote Assessment, Characterization, Evaluation of Patients with ALK Drug Resistance (SPACEWALK)

Amount
$100K–$200K
Period
2018-12-15 → 2021-11-30
PIs
1

Awarded at DANA-FARBER CANCER INST

Recent Public Signals

  1. New paper: EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway (Cancer Discovery)2026-06-22
  2. New NIH award: Project 12022-08-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-30

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-0928-5244

Professor Insights

Career Trajectory